🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

TheUrologyFoundation is pleased to support Testicular Cancer Month - testicular cancer has a high survival rate if caught early - check your self regularly and if you notice any changes go and see your GP - don't wait! #testicularcancerawareness #dontwait #seeyourGP #TUF #TUFNutsTuesday

A great sunset to accompany an evening run through Exmouth.

The sun setting on Boundary Park, and sadly Oldham Athletic’s time in the Football League. For now at least

Tumor samples vary in purity and ploidy, both of which confound DNA methylation measures from bulk sequencing. We developed CAMDAC to clean up this signal. Here's our extended preprint with new insights from applying CAMDAC to TRACERx lung RRBS data: biorxiv.org/content/10.110…

In our manuscript by the Genomics of #MPNST (GeM) consortium, we present the analysis of ~100 #MPNSTs using #WGS, RNAseq, EPIC arrays and multi-reg. exome seq. A summary of key findings, including modes of #MPNST evolution & detection of prognostic copy number patterns in cfDNA👇

Very proud of @DrAllyCat for flying through her PhD viva. It’s been great to have been part of the supervisory team. On to the next academic adventure! #cancergenomics #colorectalcancer #exceptionalsurvivors

Excited to be at the #AUA2022 to present the results of the iROC trial comparing iRARC and ORC. Press event today, podium tomorrow

Great work form the iROC team John Kelly, jim catto, Pramit Khetrapal & everyone one else involved, including support from TheUrologyFoundation and The Champniss Foundation

Great opportunity to join the Mair lab (mair-lab.com) in Cambridge. Two fantastic projects: 1) astrocytoma biology jobs.cam.ac.uk/job/34480/, 2) jobs.cam.ac.uk/job/34480/ in collaboration with the Massie_Lab on ctDNA epigenetics & Nanopore #CRUK_ACED

Another wonderful day of science at #EACR #LiquidBiopsies! I am very excited to share my work on #cfDNA analysis in #paediatriccancer Drop by poster #89 to hear more!

UPDATE: The BRCA-DIRECT study has delivered #GeneticTesting results to over 600 people with #BreastCancer. Shout-out to Michael Hubank, Suzanne MacMahon and the whole team in the Centre of Molecular Pathology for continuing to deliver test results for our participants!

Well done TRACEPIGEN Ismail Moghul, Simon Rodney & Stephan Beck. Comparison and imputation-aided integration of five commercial platforms for targeted DNA methylome analysis. nature.com/articles/s4158

😢 Meanwhile… it has become almost fashionable to announce leaving the UK to work elsewhere in Europe

Great opportunity for anyone interested in #epigenetics & #braintumor research.

Great work from Christopher Steele, Peter Van Loo, The Alexandrov Lab UC San Diego and @NischalanP. Signatures of copy number alterations. From #sarcoma to pan-cancer nature.com/articles/s4158…

We found that upfront cfDNA NGS in pts with newly diagnosed mNSCLC increased the tier 1 variant detection rate by 46% vs tissue alone and halves time to treatment. It is time for a ‘Plasma-first’ cfDNA-NGS approach in NSCLC Sanjay Popat #LCSM sciencedirect.com/science/articl…

Just published! The model development for predicting urinary tract cancer in patients with haematuria! Why not try it out? Download the ‘IDENTIFY risk calculator’ app on apple and android! BURST Urology Eur Urol Focus @PelvicERAS Matt Nielsen, MD Veeru Kasi doi.org/10.1016/j.euf.…

Following the conclusion of negotiations, the sale of Oldham Athletic AFC can now be confirmed. We are also at an advanced stage to purchase Boundary Park Stadium, hopefully within the course of the next week. #oafc

For those who missed the original announcement: the Integrative Cancer Genomics lab at CCB_VIB_KUL & Department of Oncology - KU Leuven is hiring an experienced wet-lab scientist. Last week to apply (and thanks for spreading the word)! 🙏

It is a startling fact, but one in every two people will suffer with a urology disease in their life time. These range from the five urology cancers to benign conditions, such as incontinence, that can blight lives. Find out more theurologyfoundation.org #urologyhealth #UAM22